← All trials
NCT02807597
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 18, 2020
- Primary completion
- Jan 31, 2024
- Completion date
- Jan 31, 2024
- First posted
- Jun 21, 2016
- Last posted
- Sep 1, 2022
- Enrollment
- 97
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
- The University of Texas, DallasLead sponsor
- The University of Texas, DallasOverall official - principal investigator
- The University of Texas, DallasSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.